GENWORTH FINANCIAL INC (GNW) stock: key figures, P/E, revenue and dividend
Financials · United States · ISIN US37247D1063
GENWORTH FINANCIAL INC financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 7.30 bn USD |
| EBIT | 539.00 m USD |
| Net income | 223.00 m USD |
| Diluted EPS – continuing operations | 0.54 USD |
Full history since 2000, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About GENWORTH FINANCIAL INC
Genworth Financial, Inc., together with its subsidiaries, provides mortgage and long-term care insurance products in the United States. It operates through two segments: Enact and Closed Block. The company offers primary mortgage, and mortgage insurance products, and contract underwriting services. It also provides long-term care insurance products that are intended to protect against the significant and escalating costs of long-term care services provided in the insured's home, assisted living, and nursing facilities. In addition, the company offers protection and retirement income products, that includes traditional and non-traditional life insurance, such as term, universal and term universal life insurance, corporate-owned life insurance, and funding agreements; fixed annuities; and variable annuities. It distributes its products through sales force, sales representatives, and digital marketing programs. Genworth Financial, Inc. was founded in 1871 and is headquartered in Glen Allen, Virginia.
More stocks
- Shandong Weigao Blood (603014.SS)
- China World Trade Center Co Ltd (600007.SS)
- Tikehau Capital SCA (TKO.PA)
- GPGI, Inc. (GPGI)
- Syntec Technology Co., Ltd. (7750.TW)
- Shanghai Zhenhua Heavy Industries Co Ltd A (600320.SS)
- CIE Automotive SA (CIE.MC)
- Optics Technology Holding Co Ltd (300489.SZ)
- PennyMac Financial Services, Inc. (PFSI)
- CarGurus, Inc. (CARG)
- Kenon Holdings (KEN)
- Kobayashi Pharmaceutical Co Ltd (4967.T)
Not investment advice. All data without warranty, price as of 02.11.2026. Details in the risk notice.